| Net Preferred Stock Issuance |
$96.84M |
-$75.00M |
$0.00 |
$0.00 |
$121.33M |
| Deferred Tax |
-$61.46M |
-$29.19M |
$0.00 |
$12.41M |
-$1.63M |
| Net Other Investing Changes |
$1.05M |
– |
– |
– |
– |
| Financing Cash Flow |
$3.64B |
$1.21B |
$1.61B |
$2.19B |
$534.63M |
| Net Cash Flow from Continuing Financing Activities |
$3.64B |
$1.21B |
$1.61B |
$2.19B |
$534.63M |
| Net Issuance Payments of Debt |
$3.65B |
$1.37B |
$1.68B |
$2.26B |
$475.80M |
| Net Common Stock Issuance |
-$12.61M |
$287,000.00 |
$233,000.00 |
$192,000.00 |
$117,000.00 |
| Cash Dividends Paid |
-$89.04M |
-$86.05M |
-$74.82M |
-$68.17M |
-$61.32M |
| Net Other Financing Activities |
-$5.11M |
-$5.35M |
-$3.01M |
-$1.84M |
-$1.31M |
| Ending Cash Balance |
$931.07M |
$1.02B |
$888.71M |
$861.00M |
$908.79M |
| Net Change in Cash |
-$92.94M |
$135.30M |
$27.71M |
-$47.78M |
-$125.16M |
| Beginning Cash Balance |
$1.02B |
$888.71M |
$861.00M |
$908.79M |
$1.03B |
| Free Cash Flow |
$80.06M |
$607.37M |
$375.80M |
$809.27M |
$436.41M |
| Net Income from Loans |
-$3.09B |
-$2.21B |
-$800.47M |
-$1.26B |
-$734.41M |
| Net Investment Purchase and Sale |
-$721.66M |
$536.32M |
-$1.15B |
-$1.78B |
-$361.79M |
| Other Non-Cash Items |
$34.46M |
$29.63M |
$31.59M |
$33.31M |
$46.97M |
| Net Income from Continuing Operations |
$207.42M |
$207.19M |
$200.00M |
$178.14M |
$136.09M |
| Net cash flow from continuing operations |
$80.06M |
$612.65M |
$375.80M |
$809.27M |
$436.41M |
| Change in Working Capital |
$22.39M |
$173.75M |
$43.62M |
-$130.50M |
$29.57M |
| -Change in Receivables |
-$59.40M |
-$31.79M |
-$65.64M |
-$62.73M |
$4.41M |
| -Change in Payables and Accrued Expense |
$38.60M |
$13.27M |
$63.95M |
$58.88M |
-$9.53M |
| -Change in Other Current Assets |
$105.74M |
$47.78M |
$54.37M |
-$126.05M |
-$9.83M |
| -Change in Other Current Liabilities |
-$62.55M |
$144.49M |
-$9.06M |
-$591,000.00 |
$44.51M |
| Net cash flow from investing |
-$3.81B |
-$1.68B |
-$1.96B |
-$3.04B |
-$1.10B |
| Net Cash Flow from Continuing Investing Activities |
-$3.81B |
-$1.68B |
-$1.96B |
-$3.04B |
-$1.10B |
| Net PPE Purchase and Sale |
$0.00 |
-$5.27M |
$0.00 |
$0.00 |
– |
| Operating Cash Flow |
$80.06M |
$612.65M |
$375.80M |
$809.27M |
$436.41M |
| Gain/Loss from Continuing Operations |
– |
– |
– |
– |
-$6.79M |
No comments yet — be the first to weigh in on AGM.